These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20335784)

  • 1. IgA nephropathy associated with Castleman disease with cutaneous involvement.
    Komatsuda A; Wakui H; Togashi M; Sawada K
    Am J Med Sci; 2010 May; 339(5):486-90. PubMed ID: 20335784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Case of mesangial proliferative glomerulonephritis complicated with multicentric Castleman's disease].
    Fujiwara H; Mise N; Ishimoto Y; Kotera N; Tanaka M; Tanaka S; Kurita N; Fujii A; Yamaguchi Y; Sugimoto T
    Nihon Jinzo Gakkai Shi; 2011; 53(2):189-94. PubMed ID: 21516705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term treatment with a humanized anti-interleukin-6 receptor antibody (tocilizumab), improving interstitial pneumonia in a patient with multicentric Castleman disease].
    Harada N; Sayama K; Tanaka K; Hasegawa N; Okamoto S; Hayashi Y; Ishizaka A
    Nihon Kokyuki Gakkai Zasshi; 2010 Feb; 48(2):145-50. PubMed ID: 20184247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous and systemic plasmacytosis vs. cutaneous plasmacytic castleman disease: review and speculations about pathogenesis.
    Haque M; Hou JS; Hisamichi K; Tamada K; Cusack CA; Abdelmalek M; Brown RE; Vonderheid EC
    Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):453-61. PubMed ID: 21940235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal involvement in multicentric Castleman disease with glomeruloid hemangioma of skin and plasmacytoma.
    Uthup S; Balachandran K; Ammal VA; Abdul Salam R; George J; Nair GM; Leela M
    Am J Kidney Dis; 2006 Aug; 48(2):e17-24. PubMed ID: 16860182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous and systemic plasmacytosis showing histopathologic features as mixed-type Castleman disease: a case report.
    Chen H; Xue Y; Jiang Y; Zeng X; Sun JF
    Am J Dermatopathol; 2012 Jul; 34(5):553-6. PubMed ID: 22172955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible cardiomyopathy associated with Multicentric Castleman disease: successful treatment with tocilizumab, an anti-interleukin 6 receptor antibody.
    Kanda J; Kawabata H; Yamaji Y; Ichinohe T; Ishikawa T; Tamura T; Furukawa Y; Kimura T; Kita T; Uchiyama T
    Int J Hematol; 2007 Apr; 85(3):207-11. PubMed ID: 17483056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of autoimmune hemolytic anemia associated with multicentric Castleman disease by anti-interleukin-6 receptor antibody (tocilizumab) therapy.
    Yuzuriha A; Saitoh T; Koiso H; Mitsui T; Uchiumi H; Yokohama A; Handa H; Kojima M; Tsukamoto N; Karaswa M; Murakami H; Nojima Y
    Acta Haematol; 2011; 126(3):147-50. PubMed ID: 21757886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of long term administration of humanized anti-interleukin-6 receptor antibody (tocilizumab) for multicentric Castleman's disease with pulmonary involvement].
    Akahane D; Kimura Y; Sumi M; Sashida G; Gotoh A; Miyazawa K; Ohyashiki K
    Rinsho Ketsueki; 2006 Aug; 47(8):748-52. PubMed ID: 16986713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic plasmacytic lymphadenopathy with polyclonal hypergammaglobulinemia accompanied with cutaneous involvement and renal dysfunction.
    Kurosawa S; Akiyama N; Ohwada A; Warabi M; Suenaga M; Kojima M; Tomiyama J
    Jpn J Clin Oncol; 2009 Oct; 39(10):682-5. PubMed ID: 19586961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of idiopathic plasmacytic lymphadenopathy with polyclonal hyperimmunoglobulinemia associated with chronic renal failure].
    Kondo M; Katoh S; Katoh T; Ida K; Shimazaki C; Nakagawa M
    Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1133-7. PubMed ID: 2287106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete regression of HIV-associated multicentric Castleman disease treated with rituximab and thalidomide.
    Stary G; Kohrgruber N; Herneth AM; Gaiger A; Stingl G; Rieger A
    AIDS; 2008 Jun; 22(10):1232-4. PubMed ID: 18525273
    [No Abstract]   [Full Text] [Related]  

  • 13. Multicentric plasma cell variant of Castleman's disease with cutaneous involvement.
    Klein WM; Rencic A; Munshi NC; Nousari CH
    J Cutan Pathol; 2004 Jul; 31(6):448-52. PubMed ID: 15186433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentric Castleman disease with cutaneous manifestations: report of 2 cases and comparison with systemic plasmacytosis.
    Higashi Y; Kanekura T; Sakamoto R; Mochitomi Y; Kanzaki T
    Dermatology; 2007; 214(2):170-3. PubMed ID: 17341868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentric Castleman disease: report of rare disease in Kuwait.
    Mohammad BA; Al-Brahim N; Kunjhibava S; Ahmad M; Ahmad M
    Gulf J Oncolog; 2009 Jul; (6):48-50. PubMed ID: 20194090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Is the best treatment for HIV-associated multicentric Castleman disease?
    Bower M; Dalla Pria A
    Clin Adv Hematol Oncol; 2012 Mar; 10(3):207-9. PubMed ID: 22402432
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of multicentric Castleman's disease with membranoproliferative glomerulonephritis type 3-like lesion.
    Nagai K; Usui J; Noguchi K; Unai K; Hiwatashi A; Arakawa Y; Togashi A; Morito N; Saito C; Yoh K; Tsuruoka S; Kojima H; Aita K; Nagata M; Yamagata K
    Pathol Int; 2011 Nov; 61(11):686-90. PubMed ID: 22029682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Castleman disease.
    Dham A; Peterson BA
    Curr Opin Hematol; 2007 Jul; 14(4):354-9. PubMed ID: 17534161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena.
    Ocio EM; Sanchez-Guijo FM; Diez-Campelo M; Castilla C; Blanco OJ; Caballero D; San Miguel JF
    Am J Hematol; 2005 Apr; 78(4):302-5. PubMed ID: 15795923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentric castleman disease in a child with primary immunodeficiency.
    Drolet JP; Lefebvre MA; Bernard C; Mitchell D; McCusker C; Mazer B
    Pediatr Blood Cancer; 2010 Dec; 55(6):1198-200. PubMed ID: 20848636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.